Sign in
4

Changes in Ownership

ACADIA PHARMACEUTICALS INC Filed Acc 0001604689-26-000009

Director acquired 2,010 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Poole Jonathan Director 2026-05-29 Option exercise +2,010 2,010 D
Derivatives
Poole Jonathan Director 2026-05-29 Option exercise · Restricted Stock Units −2,010 0 D
Poole Jonathan Director 2026-05-29 Grant or award · Director Stock Options (Right to Buy) +16,004 16,004 D
Poole Jonathan Director 2026-05-29 Grant or award · Restricted Stock Units +9,311 9,311 D
Loading xslF345X06/form4-06012026_060606.xml…